GENE ONLINE|News &
Opinion
Blog

Licensing
Resilience, Harvard University Ink 5-Year Strategic R&D Alliance Leveraging Biomedical Innovation for a Resilient Tomorrow
2021-10-16
Takeda Collaborates with Immusoft to Advance Treatments in Rare Metabolic Diseases
2021-10-15
Takeda Inks $3.6 Billion Deal with Poseida to Advance Non-Viral Gene Therapies and Overcome Safety Issues
2021-10-13
Takeda Embarks On a Billion-Dollar Gene Therapy Deal with Selecta Biosciences
2021-10-08
Voyager Therapeutics’ Novel AAV Capsid Tech for Gene Therapy Attracts Pfizer’s Investment
2021-10-07
Xencor and Janssen Join Forces Against B-cell Lymphoma in a New Billion-Dollar Deal
2021-10-05
Wanting In on US Market, Cynata Taps Fujifilm to Advance Stem Cell Products
2021-10-01
Syndax, Incyte Sign $602 Million Collab to Advance Monoclonal Antibody
2021-09-29
Moderna Inks Deal with AbCellera to Develop Therapeutic Antibodies for mRNA Medicines
2021-09-15
AbbVie Strikes Gene Therapy Pact with REGENXBIO to Tackle Eye Diseases
2021-09-14
Eli Lilly Forays Into RNA Editing, Betting More than a Billion Dollars on ProQR’s Technology
2021-09-09
AM-Pharma Partners with Kyowa Kirin in $289m Deal for Kidney Drug
2021-09-09
Adaptimmune Therapeutics Breaks Rough Patch With New Multibillion-Dollar Collaboration
2021-09-08
Roche Bets on Shape’s RNA Editing Tech in $3B Gene Therapy Collab
2021-08-25
Vertex Inks $1.2B Pact with Feng Zhang Cofounded Startup to Develop Gene Therapies for Blood Diseases
2021-08-25
1 2 3
LATEST
10x Genomics Eyes Regional Opportunities in Asia-Pacific, Launches First Overseas Manufacturing Hub
2021-10-26
Shaping the Future of the Beauty Industry: Can Skin Microbiome Products Succeed Cosmetics?
2021-10-25
Sanofi, Regeneron’s Dupixent Shines in Phase 3 Trial for Prurigo Nodularis
2021-10-25
ReCode Therapeutics Raises $80 Million in Series B to Advance Gene Therapy & LNP Delivery Platform
2021-10-23
Intellia’s CRISPR Drug Claims FDA Orphan Drug Designation to Treat ATTR Amyloidosis
2021-10-22
Sio Gene Therapies Touts Positive Safety and Biomarker Data for GM1 Gangliosidosis Candidate
2021-10-22
Daiichi Sankyo to Launch mRNA Covid-19 Vaccine in 2022, Shionogi Presents Clinical Results of Covid-19 Oral Drug
2021-10-22
Scroll to Top

Create an account with us now to say goodbye to all the pop-ups!